David Steinberg
Stock Analyst at Jefferies
(2.77)
# 1,911
Out of 4,711 analysts
35
Total ratings
57.14%
Success rate
17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Upgrades: Buy | $9 → $16 | $7.47 | +114.19% | 6 | Sep 20, 2023 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $25.75 | +144.66% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $35.43 | +12.90% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $122.97 | +52.88% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $8.50 | -5.88% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $3.39 | +253.98% | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | $27 | $0.42 | +6,327.04% | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | $20 | $3.23 | +519.20% | 1 | Sep 22, 2017 |
Bausch Health Companies
Sep 20, 2023
Upgrades: Buy
Price Target: $9 → $16
Current: $7.47
Upside: +114.19%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $25.75
Upside: +144.66%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $35.43
Upside: +12.90%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $122.97
Upside: +52.88%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $8.50
Upside: -5.88%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $3.39
Upside: +253.98%
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: $27
Current: $0.42
Upside: +6,327.04%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%